anonymous
Guest
anonymous
Guest
Arjo outcome based strategy will fail.
I disagree diligent and proact are outcome based programs.
Arjo outcome based strategy will fail.
It haunts still, Sigouin provided the boost competition needed. Without this crucial mistake, Arjo would be in a much better position today. She discontinued over $50 million worth of equipment, Arjo lost most of it to competition. Shame of on you Anne.
Outcome based selling strategy requires you either have exclusive technology and/or control over outputs. In medical industry you either have exclusive feature(s) which has significant impact, or you can ensure better compliance to best practices.